← Mechanisms of action
TGFB2
SINGLE PROTEINHomo sapiens
Preferred name: Transforming growth factor beta-2 ChEMBL ↗
Linked proteins
Drugs acting on this target (17)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bms-986416 | Antagonist | experimental | Recombinant protein | TGFB2 antagonist |
| tst005 | Antagonist | experimental | Recombinant protein | TGFB2 antagonist |
| atb-320 | Antisense inhibitor | experimental | Nucleic acid | TGFB2 antisense inhibitor |
| taso-001 | Antisense inhibitor | experimental | Nucleic acid | TGFB2 antisense inhibitor |
| tgf-β2 antisense oligonucleotide | Antisense inhibitor | experimental | Nucleic acid | TGFB2 antisense inhibitor |
| trabedersen | Antisense inhibitor | experimental | Nucleic acid | TGFB2 antisense inhibitor |
| gpc3 and/or tgfβ targeting car-t cells | Immunity, passive | experimental | Cell therapy | TGFB2 immunity, passive |
| bpb-101 | Inhibitor | experimental | mAb | TGFB2 inhibitor |
| cospherunate | Inhibitor | experimental | Small molecule | TGFB2 inhibitor |
| dr30206 | Inhibitor | experimental | mAb | TGFB2 inhibitor |
| gc1008 | Inhibitor | experimental | mAb | TGFB2 inhibitor |
| ker-050 | Inhibitor | experimental | Recombinant protein | TGFB2 inhibitor |
| lerdelimumab | Inhibitor | experimental | mAb | TGFB2 inhibitor |
| sh3051 | Inhibitor | experimental | Small molecule | TGFB2 inhibitor |
| vactosertib | Inhibitor | experimental | Small molecule | TGFB2 inhibitor |
| Yifenidone | Inhibitor | experimental | Small molecule | TGFB2 inhibitor |
| zggs18 | Inhibitor | experimental | mAb | TGFB2 inhibitor |